Total Visits

Views
Osimertinib is selective against NSCLC cells and modulates the multidrug-resistant phenotype in patient-derived cell cultures and co-cultures of NSCLC cells and fibroblasts114

Total Visits Per Month

December 2023January 2024February 2024March 2024April 2024May 2024June 2024
Osimertinib is selective against NSCLC cells and modulates the multidrug-resistant phenotype in patient-derived cell cultures and co-cultures of NSCLC cells and fibroblasts16718771

File Visits

Views
bitstream_12989.pdf40

Top country views

Views
Australia1
Singapore1
Ukraine1

Top cities views

Views
Melbourne1
Odesa1